You are here

Antimicrobial resistance: we need to act now

24 Sep 2021
All Committees

Antimicrobial drugs are undervalued for their revolutionary impact on human society. Their discovery in the early 20th century corresponds with a dramatic increase in global life expectancy. Thanks to the development of various classes of antimicrobial agents throughout the last century, death at the hands of bacterial infection has become significantly less of a risk. However, the emergence of drug-resistant bacteria serves to dilute the effectiveness of antimicrobial agents. Andrea Chiarello (Pfizer), Chair, Healthcare Committee shares why we need to act now on antimicrobial resistance.

Antimicrobial resistance